| Identification | Back Directory | [Name]
Rob 803 | [CAS]
872178-65-9 | [Synonyms]
Rob 803 RabexiMod Chinfloxacin Hydrochloride 2-(9-chloro-2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide 6H-Indolo[2,3-b]quinoxaline-6-acetamide, 9-chloro-N-[2-(dimethylamino)ethyl]-2,3-dimethyl- | [Molecular Formula]
C22H24ClN5O | [MDL Number]
MFCD18633308 | [MOL File]
872178-65-9.mol | [Molecular Weight]
409.91 |
| Hazard Information | Back Directory | [Uses]
Rabeximod (ROB-803), an anti-rheumatic compound, impairs the differentiation and function of human pro-inflammatory dendritic cells and macrophages via downregulating TLR2 and TLR4 stimulation. Rabeximod (ROB-803) is used for rheumatoid arthritis (RA) research[1]. | [IC 50]
TLR2; TLR4 | [References]
[1] Pablo Giusti, et al. The novel anti-rheumatic compound Rabeximod impairs differentiation and function of human pro-inflammatory dendritic cells and macrophages. Immunobiology. 2011 Jan-Feb;216(1-2):243-50. DOI:10.1016/j.imbio.2010.04.004 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|